Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
Hamilton
G
G
First Department of Surgery, University School of Medicine, Vienna, Austria.
Mühlbacher
F
F
Steininger
R
R
Havel
M
M
Kreuzer
S
S
Laengle
F
F
Piza
F
F
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D012016:Reference Values
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone